title: In a patient with toxic epidermal necrolysis, does intravenous immunoglobulin improve survival compared with supportive care?
authors.affiliation: Department of Dermatology, Queens Medical Centre, Nottingham University Hospitals Trust, Nottingham, England. ciwootton@aol.com
authors.forename: Catriona Isobel
authors.initials: CI
authors.lastname: Wootton
authors.forename: Anand Neel
authors.initials: AN
authors.lastname: Patel
authors.forename: Hywel C
authors.initials: HC
authors.lastname: Williams
mesh_terms: D000368:Aged; D000927:Anticonvulsants / Q000009:adverse effects / Q000627:therapeutic use; D001706:Biopsy; D004827:Epilepsy / Q000188:drug therapy; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D007155:Immunologic Factors / Q000627:therapeutic use*; D000077213:Lamotrigine; D008297:Male; D012720:Severity of Illness Index; D013262:Stevens-Johnson Syndrome / Q000209:etiology / Q000503:physiopathology / Q000628:therapy*; D016896:Treatment Outcome; D014227:Triazines / Q000009:adverse effects / Q000627:therapeutic use
chemical_list: D000927:Anticonvulsants; D016756:Immunoglobulins, Intravenous; D007155:Immunologic Factors; D014227:Triazines; D000077213:Lamotrigine